Leonard Schaeffer - Iqvia Holdings Independent Director

<div class='circular--portrait' style='background:#0D52D1;color: white;font-size:5em;padding-top: 5px;;'>Q</div>
  Director
Mr. Leonard D. Schaeffer is Independent Director of Quintiles Transnational Holdings Inc. He has served as a partner of North Bristol Partners LLC a privately held consulting company since 2006. From 2007 to 2011 Mr. Schaeffer served as the Chairman of the Board of Surgical Care Affiliates LLC then a privately held company operating a national network of ambulatory surgical centers and surgical hospitals. Mr. Schaeffer formerly served as Chairman of the Board of WellPoint Inc. then the largest health insurance company in the United States Chairman and Chief Executive Officer of WellPoint Health Networks Inc. and Chairman and Chief Executive Officer of Blue Cross California and as a director of Allergan Inc. a publicly traded specialty pharmaceutical company and as a director of Amgen Inc. a publicly traded biotechnology company . Mr. Schaeffer now serves on the boards of Walgreens Boots Alliance a publicly traded pharmaceutical manufacturing wholesale and distribution holding company and scPharmaceuticals a privately held medical device company. While serving in the federal government from 1978 to 1980 Mr. Schaeffer was Administrator of the Health Care Financing Administration and was responsible for the United States Medicare and Medicaid programs. Mr. Schaeffer was named the Judge Widney Professor and Chair at the University of Southern California in 2007 and serves on the boards of the Brookings Institution the RAND Corporationrationration the University of Southern California and on the Board of Fellows of Harvard Medical School. He is a member of the Institute of Medicine of the National Academy of Sciences
Age: 69  Director Since 2008      
919-998-2000  www.quintiles.com
Schaeffer received his Bachelor of Arts from Princeton University in 1969.

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. Iqvia Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Rona FairheadHSBC HOLDINGS PLC
2004
John BellRoche Holdings Ag Beare
2001
Yun LeeHSBC HOLDINGS PLC
2015
Joachim FaberHSBC HOLDINGS PLC
2012
Mark McCombeIshares FtseXinhua A50
2012
David NishHSBC HOLDINGS PLC
2016
Anita HauserRoche Holdings Ag Beare
2017
Jose KuribrenaHSBC HOLDINGS PLC
2019
Paul BulckeRoche Holdings Ag Beare
2011
Graham TurlIshares FtseXinhua A50
2014
Claudia DyckerhoffRoche Holdings Ag Beare
2016
Pauline MohrHSBC HOLDINGS PLC
2015
Kathleen CaseyHSBC HOLDINGS PLC
2014
Peter VoserRoche Holdings Ag Beare
2011
John LipskyHSBC HOLDINGS PLC
2012
Beatrice MauroRoche Holdings Ag Beare
2006
Jackson TaiHSBC HOLDINGS PLC
2016
Paul WalshHSBC HOLDINGS PLC
2016
Jane LeungIshares FtseXinhua A50
2012
Ewen StevensonHSBC HOLDINGS PLC
2019
Richard LiftonRoche Holdings Ag Beare
2015

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Iqvia Holdings (Q) is traded on BATS Exchange in USA and employs 36,100 people.

Iqvia Holdings Leadership Team

Thomas Pike, CEO and Director
Ari Bousbib, Director
Michael Evanisko, Independent Director
Leonard Schaeffer, Independent Director
James Erlinger, Executive Vice President General Counsel, Secretary
John Danhakl, Director
Richard Staub, President - Research and Development Solutions
Michael McDonnell, CFO, Executive Vice President
Kevin Gordon, COO
John Leonard, Independent Director
James Fasano, Director
Jonathan Coslet, Director
John Connaughton, Director
Haiyuan Lo, Director
Ronald Rittenmeyer, Director
Dennis Gillings, Executive Chairman of the Board
Todd Sisitsky, Director
Jack Greenberg, Independent Director
Kevin Knightly, President - Information and Technology Solutions

Stock Performance Indicators

Current Sentiment - Q

Iqvia Holdings Investor Sentiment

More than half of Macroaxis users are at this time bullish on Iqvia Holdings. What is your judgment towards investing in Iqvia Holdings? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

ALNY   
Purchased few shares of
few hours ago
Traded for 1.0
TWTR   
Purchased over 50 shares of
few hours ago
Traded for 1.0
BTCS   
Purchased over 100 shares of
few hours ago
Traded for 1.0
BTSC   
Purchased over 10K shares of
few hours ago
Traded for 1.0
SQ   
Purchased few shares of
few hours ago
Traded for 1.0
See also Your Equity Center. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.